Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,795 | 186 | 92.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $215.00 | 3 | 7.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $387.25 | 47 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $310.38 | 23 | $0 (2020) |
| Lilly USA, LLC | $291.66 | 23 | $0 (2022) |
| GlaxoSmithKline, LLC. | $275.72 | 9 | $0 (2023) |
| Novo Nordisk Inc | $273.20 | 20 | $0 (2023) |
| Kowa Pharmaceuticals America, Inc. | $193.87 | 8 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $183.96 | 15 | $0 (2019) |
| GENZYME CORPORATION | $180.00 | 2 | $0 (2019) |
| ABBVIE INC. | $162.57 | 4 | $0 (2022) |
| Amgen Inc. | $137.47 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.48 | 1 | PFIZER INC. ($16.48) |
| 2023 | $40.29 | 3 | GlaxoSmithKline, LLC. ($25.81) |
| 2022 | $127.05 | 3 | GlaxoSmithKline, LLC. ($96.88) |
| 2021 | $15.29 | 1 | AbbVie Inc. ($15.29) |
| 2020 | $130.09 | 2 | GlaxoSmithKline, LLC. ($95.09) |
| 2019 | $763.01 | 29 | GENZYME CORPORATION ($180.00) |
| 2018 | $776.58 | 70 | PFIZER INC. ($157.19) |
| 2017 | $1,142 | 80 | PFIZER INC. ($186.68) |
All Payment Transactions
189 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/29/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: VACCINES | ||||||
| 10/24/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Diabetes | ||||||
| 09/26/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: RESPIRATORY | ||||||
| 08/15/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: RESPIRATORY | ||||||
| 07/26/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Diabetes | ||||||
| 05/26/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: NEUROSCIENCE | ||||||
| 04/07/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $96.88 | General |
| Category: VACCINES | ||||||
| 09/18/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2020 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $95.09 | General |
| Category: VACCINES | ||||||
| 02/20/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $35.00 | General |
| Category: Endocrinology | ||||||
| 10/09/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/19/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: DIABETES | ||||||
| 07/24/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: UROLOGY | ||||||
| 07/18/2019 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $109.69 | General |
| Category: Endocrinology | ||||||
| 06/20/2019 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Endocrinology | ||||||
| 06/17/2019 | Aytu BioScience, Inc | ZolpiMist (Drug) | Food and Beverage | Cash or cash equivalent | $17.73 | General |
| Category: Urology | ||||||
| 06/13/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: DIABETES | ||||||
| 06/07/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: UROLOGY | ||||||
| 06/03/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Diabetes | ||||||
| 05/20/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Hypertriglyceridemia | ||||||
| 05/13/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: VACCINES | ||||||
| 05/07/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: RESPIRATORY | ||||||
| 05/06/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Hypertriglyceridemia | ||||||
| 04/29/2019 | Aytu BioScience, Inc | Tuzistra XR (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: antitussive | ||||||
| 04/23/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $12.41 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 953 | 1,337 | $163,561 | $47,416 |
| 2022 | 14 | 926 | 1,286 | $139,799 | $36,324 |
| 2021 | 19 | 1,349 | 1,741 | $157,277 | $84,924 |
| 2020 | 19 | 1,094 | 1,513 | $149,013 | $68,622 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 158 | 223 | $25,519 | $9,131 | 35.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 127 | 167 | $29,300 | $6,908 | 23.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 78 | 117 | $28,686 | $5,492 | 19.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 55 | $10,950 | $4,884 | 44.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 202 | 379 | $4,169 | $3,158 | 75.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 40 | 40 | $3,102 | $2,940 | 94.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 25 | 31 | $9,896 | $2,410 | 24.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 21 | $4,416 | $2,033 | 46.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 17 | 20 | $4,100 | $1,703 | 41.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 13 | $4,016 | $1,683 | 41.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 23 | $3,173 | $1,357 | 42.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 33 | 33 | $2,368 | $1,245 | 52.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 42 | 43 | $1,591 | $1,201 | 75.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 16 | 17 | $2,354 | $1,022 | 43.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 122 | 122 | $27,572 | $914.75 | 3.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 17 | 18 | $1,899 | $905.04 | 47.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 15 | $450.00 | $429.00 | 95.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 169 | 251 | $28,112 | $9,784 | 34.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 121 | 163 | $28,036 | $6,431 | 22.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 68 | 110 | $26,400 | $5,329 | 20.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 52 | 52 | $3,719 | $3,634 | 97.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 45 | $6,120 | $2,397 | 39.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 62 | 62 | $4,340 | $2,088 | 48.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 55 | 55 | $2,021 | $1,511 | 74.8% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 25 | 25 | $2,575 | $1,264 | 49.1% |
About Dr. David Karty, MD
Dr. David Karty, MD is a Family Medicine healthcare provider based in Olathe, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144272949.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Karty, MD has received a total of $3,010 in payments from pharmaceutical and medical device companies, with $16.48 received in 2024. These payments were reported across 189 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,795).
As a Medicare-enrolled provider, Karty has provided services to 4,322 Medicare beneficiaries, totaling 5,877 services with total Medicare billing of $237,286. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Olathe, KS
- Active Since 05/17/2006
- Last Updated 01/24/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1144272949
Products in Payments
- CHANTIX (Drug) $259.64
- TOUJEO (Drug) $230.48
- TRULICITY (Drug) $220.75
- Livalo (Drug) $193.87
- Synthroid (Drug) $133.14
- Repatha (Biological) $127.36
- SOLIQUA (Drug) $117.98
- SYMBICORT (Drug) $112.71
- XIFAXAN (Drug) $107.32
- BEXSERO (Biological) $106.24
- Victoza (Drug) $105.01
- SHINGRIX (Biological) $96.88
- SOLIQUA 100/33 (Drug) $93.93
- Ozempic (Drug) $88.82
- Vascepa (Drug) $75.24
- TRADJENTA (Drug) $70.91
- Tresiba (Drug) $52.80
- YOSPRALA (Drug) $51.62
- FARXIGA (Drug) $47.27
- DUEXIS (Drug) $42.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Olathe
Constance Irick, M.d, M.D
Family Medicine — Payments: $21,543
Travis Keller, Md, MD
Family Medicine — Payments: $13,363
Dr. Fred Church, D.o, D.O
Family Medicine — Payments: $13,106
Dr. Holly Kaufman, M.d, M.D
Family Medicine — Payments: $12,247
Dr. Anthony Justesen, Md, MD
Family Medicine — Payments: $5,767
Dr. Young Cho, M.d, M.D
Family Medicine — Payments: $5,229